PDB Short entry for 3F7H HEADER APOPTOSIS 09-NOV-08 3F7H TITLE STRUCTURE OF AN ML-IAP/XIAP CHIMERA BOUND TO A PEPTIDOMIMETIC COMPND MOL_ID: 1; COMPND 2 MOLECULE: BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 7; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: ML-IAP RESIDUES 63-172; COMPND 5 SYNONYM: KIDNEY INHIBITOR OF APOPTOSIS PROTEIN, KIAP, MELANOMA COMPND 6 INHIBITOR OF APOPTOSIS PROTEIN, ML-IAP, LIVIN, RING FINGER PROTEIN COMPND 7 50; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BIRC7, KIAP, LIVIN, MLIAP, RNF50, UNQ5800/PRO19607/PRO21344; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS ZINC BINDING, PEPTIDE COMPLEX, APOPTOSIS INHIBITION, PEPTIDOMIMETIC, KEYWDS 2 SMALL MOLECULE, DRUG DESIGN, APOPTOSIS, METAL-BINDING, NUCLEUS, KEYWDS 3 ZINC-FINGER EXPDTA X-RAY DIFFRACTION AUTHOR M.C.FRANKLIN,W.J.FAIRBROTHER,F.COHEN REVDAT 7 03-APR-24 3F7H 1 REMARK REVDAT 6 27-DEC-23 3F7H 1 REMARK REVDAT 5 20-OCT-21 3F7H 1 REMARK SEQADV LINK REVDAT 4 25-OCT-17 3F7H 1 REMARK REVDAT 3 13-JUL-11 3F7H 1 VERSN REVDAT 2 31-MAR-09 3F7H 1 JRNL REVDAT 1 17-MAR-09 3F7H 0 JRNL AUTH F.COHEN,B.ALICKE,L.O.ELLIOTT,J.A.FLYGARE,T.GONCHAROV, JRNL AUTH 2 S.F.KETELTAS,M.C.FRANKLIN,S.FRANKOVITZ,J.P.STEPHAN,V.TSUI, JRNL AUTH 3 D.VUCIC,H.WONG,W.J.FAIRBROTHER JRNL TITL ORALLY BIOAVAILABLE ANTAGONISTS OF INHIBITOR OF APOPTOSIS JRNL TITL 2 PROTEINS BASED ON AN AZABICYCLOOCTANE SCAFFOLD JRNL REF J.MED.CHEM. V. 52 1723 2009 JRNL REFN ISSN 0022-2623 JRNL PMID 19228017 JRNL DOI 10.1021/JM801450C REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH K.ZOBEL,L.WANG,E.VARFOLOMEEV,M.C.FRANKLIN,L.O.ELLIOTT, REMARK 1 AUTH 2 H.J.WALLWEBER,D.C.OKAWA,J.A.FLYGARE,D.VUCIC,W.J.FAIRBROTHER, REMARK 1 AUTH 3 K.DESHAYES REMARK 1 TITL DESIGN, SYNTHESIS, AND BIOLOGICAL ACTIVITY OF A POTENT SMAC REMARK 1 TITL 2 MIMETIC THAT SENSITIZES CANCER CELLS TO APOPTOSIS BY REMARK 1 TITL 3 ANTAGONIZING IAPS. REMARK 1 REF ACS CHEM. BIOL. V. 1 525 2006 REMARK 1 REFN ISSN 1554-8929 REMARK 1 PMID 17168540 REMARK 1 REFERENCE 2 REMARK 1 AUTH D.VUCIC,M.C.FRANKLIN,H.J.WALLWEBER,K.DAS,B.P.ECKELMAN, REMARK 1 AUTH 2 H.SHIN,L.O.ELLIOTT,K.DESHAYES,G.S.SALVESEN,W.J.FAIRBROTHER REMARK 1 TITL ENGINEERING ML-IAP TO PRODUCE AN EXTRAORDINARILY POTENT REMARK 1 TITL 2 CASPASE-9 INHIBITOR: IMPLICATIONS FOR SMAC-DEPENDENT REMARK 1 TITL 3 ANTI-APOPTOTIC ACTIVITY OF ML-IAP. REMARK 1 REF BIOCHEM. J. V. 385 11 2005 REMARK 1 REFN ISSN 0264-6021 REMARK 1 PMID 15485396 REMARK 1 REFERENCE 3 REMARK 1 AUTH M.C.FRANKLIN,S.KADKHODAYAN,H.ACKERLY,D.ALEXANDRU, REMARK 1 AUTH 2 M.D.DISTEFANO,L.O.ELLIOTT,J.A.FLYGARE,D.VUCIC,K.DESHAYES, REMARK 1 AUTH 3 W.J.FAIRBROTHER REMARK 1 TITL STRUCTURE AND FUNCTION ANALYSIS OF PEPTIDE ANTAGONISTS OF REMARK 1 TITL 2 MELANOMA INHIBITOR OF APOPTOSIS (ML-IAP) REMARK 1 REF BIOCHEMISTRY V. 42 8223 2003 REMARK 1 REFN ISSN 0006-2960 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 25848 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.150 REMARK 3 R VALUE (WORKING SET) : 0.149 REMARK 3 FREE R VALUE : 0.175 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1359 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1823 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.01 REMARK 3 BIN R VALUE (WORKING SET) : 0.1830 REMARK 3 BIN FREE R VALUE SET COUNT : 93 REMARK 3 BIN FREE R VALUE : 0.2110 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1479 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 101 REMARK 3 SOLVENT ATOMS : 209 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 23.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.34 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.70000 REMARK 3 B22 (A**2) : -0.70000 REMARK 3 B33 (A**2) : 1.41000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.085 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.084 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.051 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.110 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.966 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.956 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1651 ; 0.010 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 1156 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2232 ; 1.108 ; 1.987 REMARK 3 BOND ANGLES OTHERS (DEGREES): 2761 ; 0.842 ; 3.004 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 181 ; 4.519 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 79 ;32.561 ;23.038 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 220 ;12.353 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 8 ;11.559 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 210 ; 0.066 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1815 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 388 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 334 ; 0.201 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 1175 ; 0.188 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 790 ; 0.186 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 686 ; 0.081 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 132 ; 0.103 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 7 ; 0.197 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 34 ; 0.220 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 26 ; 0.144 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1172 ; 1.834 ; 2.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 370 ; 0.283 ; 2.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1446 ; 2.117 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 915 ; 1.937 ; 2.500 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 786 ; 2.888 ; 5.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 78 A 167 REMARK 3 RESIDUE RANGE : A 1001 A 1001 REMARK 3 ORIGIN FOR THE GROUP (A): 85.3956 68.8775 22.1313 REMARK 3 T TENSOR REMARK 3 T11: -0.1792 T22: -0.1461 REMARK 3 T33: -0.1763 T12: 0.0027 REMARK 3 T13: 0.0098 T23: -0.0016 REMARK 3 L TENSOR REMARK 3 L11: 2.0506 L22: 3.3064 REMARK 3 L33: 1.8859 L12: -1.0483 REMARK 3 L13: -0.2444 L23: 0.1715 REMARK 3 S TENSOR REMARK 3 S11: 0.0801 S12: 0.1799 S13: -0.0288 REMARK 3 S21: -0.2570 S22: -0.0943 S23: -0.0137 REMARK 3 S31: -0.0201 S32: 0.0019 S33: 0.0142 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 78 B 170 REMARK 3 RESIDUE RANGE : B 1001 B 1001 REMARK 3 ORIGIN FOR THE GROUP (A): 78.6069 60.1907 49.8584 REMARK 3 T TENSOR REMARK 3 T11: -0.1726 T22: -0.1766 REMARK 3 T33: -0.1787 T12: -0.0128 REMARK 3 T13: 0.0160 T23: 0.0005 REMARK 3 L TENSOR REMARK 3 L11: 1.4720 L22: 3.2105 REMARK 3 L33: 1.6620 L12: -0.4339 REMARK 3 L13: 0.3904 L23: -1.2021 REMARK 3 S TENSOR REMARK 3 S11: 0.0075 S12: -0.1153 S13: -0.0393 REMARK 3 S21: 0.1905 S22: 0.0046 S23: 0.0654 REMARK 3 S31: -0.0561 S32: -0.0102 S33: -0.0121 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3F7H COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-NOV-08. REMARK 100 THE DEPOSITION ID IS D_1000050242. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-MAR-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL, CYLINDRICALLY REMARK 200 BENT, SI(220) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27289 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 7.100 REMARK 200 R MERGE (I) : 0.08200 REMARK 200 R SYM (I) : 0.08200 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 24.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.4 REMARK 200 DATA REDUNDANCY IN SHELL : 6.40 REMARK 200 R MERGE FOR SHELL (I) : 0.45700 REMARK 200 R SYM FOR SHELL (I) : 0.45700 REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: DIFFERENCE FOURIER REMARK 200 SOFTWARE USED: DIFFERENCE FOURIER REMARK 200 STARTING MODEL: 1.3 A STRUCTURE OF THE ML-IAP/XIAP PROTEIN BOUND REMARK 200 TO A DIFFERENT PEPTIDOMIMETIC, WITH THE LIGAND AND SURROUNDING REMARK 200 WATERS REMOVED REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.14 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: LITHIUM SULFATE, PEG 3350, BIS-TRIS, REMARK 280 PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 36.66050 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 44.02400 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 44.02400 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 18.33025 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 44.02400 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 44.02400 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 54.99075 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 44.02400 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 44.02400 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 18.33025 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 44.02400 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 44.02400 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 54.99075 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 36.66050 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: AUTHORS STATE THAT EACH ASYMMETRIC UNIT CONTAINS TWO REMARK 300 BIOLOGICAL ASSEMBLIES OF PROTEIN AND LIGAND REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 189 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 299 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 253 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 40 REMARK 465 GLY A 41 REMARK 465 SER A 42 REMARK 465 SER A 43 REMARK 465 HIS A 44 REMARK 465 HIS A 45 REMARK 465 HIS A 46 REMARK 465 HIS A 47 REMARK 465 HIS A 48 REMARK 465 HIS A 49 REMARK 465 SER A 50 REMARK 465 SER A 51 REMARK 465 GLY A 52 REMARK 465 GLU A 53 REMARK 465 VAL A 54 REMARK 465 PRO A 55 REMARK 465 ARG A 56 REMARK 465 GLY A 57 REMARK 465 SER A 58 REMARK 465 HIS A 59 REMARK 465 MET A 60 REMARK 465 LEU A 61 REMARK 465 GLU A 62 REMARK 465 THR A 63 REMARK 465 GLU A 64 REMARK 465 GLU A 65 REMARK 465 GLU A 66 REMARK 465 GLU A 67 REMARK 465 GLU A 68 REMARK 465 GLU A 69 REMARK 465 GLY A 70 REMARK 465 ALA A 71 REMARK 465 GLY A 72 REMARK 465 ALA A 73 REMARK 465 THR A 74 REMARK 465 LEU A 75 REMARK 465 SER A 76 REMARK 465 ARG A 77 REMARK 465 LEU A 168 REMARK 465 THR A 169 REMARK 465 HIS A 170 REMARK 465 SER A 171 REMARK 465 LEU A 172 REMARK 465 MET B 40 REMARK 465 GLY B 41 REMARK 465 SER B 42 REMARK 465 SER B 43 REMARK 465 HIS B 44 REMARK 465 HIS B 45 REMARK 465 HIS B 46 REMARK 465 HIS B 47 REMARK 465 HIS B 48 REMARK 465 HIS B 49 REMARK 465 SER B 50 REMARK 465 SER B 51 REMARK 465 GLY B 52 REMARK 465 GLU B 53 REMARK 465 VAL B 54 REMARK 465 PRO B 55 REMARK 465 ARG B 56 REMARK 465 GLY B 57 REMARK 465 SER B 58 REMARK 465 HIS B 59 REMARK 465 MET B 60 REMARK 465 LEU B 61 REMARK 465 GLU B 62 REMARK 465 THR B 63 REMARK 465 GLU B 64 REMARK 465 GLU B 65 REMARK 465 GLU B 66 REMARK 465 GLU B 67 REMARK 465 GLU B 68 REMARK 465 GLU B 69 REMARK 465 GLY B 70 REMARK 465 ALA B 71 REMARK 465 GLY B 72 REMARK 465 ALA B 73 REMARK 465 THR B 74 REMARK 465 LEU B 75 REMARK 465 SER B 76 REMARK 465 ARG B 77 REMARK 465 SER B 171 REMARK 465 LEU B 172 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 119 -132.45 47.29 REMARK 500 GLN B 119 -142.38 48.11 REMARK 500 TYR B 128 -16.79 79.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1001 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 124 SG REMARK 620 2 CYS A 127 SG 105.0 REMARK 620 3 HIS A 144 NE2 99.8 119.0 REMARK 620 4 CYS A 151 SG 117.3 108.7 107.4 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 LI B1002 LI REMARK 620 N RES CSSEQI ATOM REMARK 620 1 SER B 93 O REMARK 620 2 ASP B 96 OD1 116.6 REMARK 620 3 HIS B 115 ND1 119.5 100.4 REMARK 620 4 EDO B 174 O2 95.5 107.4 117.8 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B1001 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B 124 SG REMARK 620 2 CYS B 127 SG 106.7 REMARK 620 3 HIS B 144 NE2 99.5 119.8 REMARK 620 4 CYS B 151 SG 117.3 106.6 107.4 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 419 A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LI B 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 419 B 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BTB B 173 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 174 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 175 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1TW6 RELATED DB: PDB REMARK 900 RELATED ID: 2I3H RELATED DB: PDB REMARK 900 RELATED ID: 2I3I RELATED DB: PDB REMARK 900 RELATED ID: 3F7G RELATED DB: PDB REMARK 900 RELATED ID: 3F7I RELATED DB: PDB DBREF 3F7H A 63 172 UNP Q6R308 Q6R308_HUMAN 63 172 DBREF 3F7H B 63 172 UNP Q6R308 Q6R308_HUMAN 63 172 SEQADV 3F7H MET A 40 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H GLY A 41 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H SER A 42 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H SER A 43 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H HIS A 44 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H HIS A 45 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H HIS A 46 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H HIS A 47 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H HIS A 48 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H HIS A 49 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H SER A 50 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H SER A 51 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H GLY A 52 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H GLU A 53 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H VAL A 54 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H PRO A 55 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H ARG A 56 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H GLY A 57 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H SER A 58 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H HIS A 59 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H MET A 60 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H LEU A 61 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H GLU A 62 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H GLY A 150 UNP Q6R308 SER 150 ENGINEERED MUTATION SEQADV 3F7H GLN A 160 UNP Q6R308 ARG 160 ENGINEERED MUTATION SEQADV 3F7H GLU A 161 UNP Q6R308 ASP 161 ENGINEERED MUTATION SEQADV 3F7H TYR A 162 UNP Q6R308 PHE 162 ENGINEERED MUTATION SEQADV 3F7H ILE A 163 UNP Q6R308 VAL 163 ENGINEERED MUTATION SEQADV 3F7H ASN A 164 UNP Q6R308 HIS 164 ENGINEERED MUTATION SEQADV 3F7H ASN A 165 UNP Q6R308 SER 165 ENGINEERED MUTATION SEQADV 3F7H ILE A 166 UNP Q6R308 VAL 166 ENGINEERED MUTATION SEQADV 3F7H HIS A 167 UNP Q6R308 GLN 167 ENGINEERED MUTATION SEQADV 3F7H LEU A 168 UNP Q6R308 GLU 168 ENGINEERED MUTATION SEQADV 3F7H LEU A 172 UNP Q6R308 GLN 172 ENGINEERED MUTATION SEQADV 3F7H MET B 40 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H GLY B 41 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H SER B 42 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H SER B 43 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H HIS B 44 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H HIS B 45 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H HIS B 46 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H HIS B 47 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H HIS B 48 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H HIS B 49 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H SER B 50 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H SER B 51 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H GLY B 52 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H GLU B 53 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H VAL B 54 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H PRO B 55 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H ARG B 56 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H GLY B 57 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H SER B 58 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H HIS B 59 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H MET B 60 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H LEU B 61 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H GLU B 62 UNP Q6R308 EXPRESSION TAG SEQADV 3F7H GLY B 150 UNP Q6R308 SER 150 ENGINEERED MUTATION SEQADV 3F7H GLN B 160 UNP Q6R308 ARG 160 ENGINEERED MUTATION SEQADV 3F7H GLU B 161 UNP Q6R308 ASP 161 ENGINEERED MUTATION SEQADV 3F7H TYR B 162 UNP Q6R308 PHE 162 ENGINEERED MUTATION SEQADV 3F7H ILE B 163 UNP Q6R308 VAL 163 ENGINEERED MUTATION SEQADV 3F7H ASN B 164 UNP Q6R308 HIS 164 ENGINEERED MUTATION SEQADV 3F7H ASN B 165 UNP Q6R308 SER 165 ENGINEERED MUTATION SEQADV 3F7H ILE B 166 UNP Q6R308 VAL 166 ENGINEERED MUTATION SEQADV 3F7H HIS B 167 UNP Q6R308 GLN 167 ENGINEERED MUTATION SEQADV 3F7H LEU B 168 UNP Q6R308 GLU 168 ENGINEERED MUTATION SEQADV 3F7H LEU B 172 UNP Q6R308 GLN 172 ENGINEERED MUTATION SEQRES 1 A 133 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 133 GLU VAL PRO ARG GLY SER HIS MET LEU GLU THR GLU GLU SEQRES 3 A 133 GLU GLU GLU GLU GLY ALA GLY ALA THR LEU SER ARG GLY SEQRES 4 A 133 PRO ALA PHE PRO GLY MET GLY SER GLU GLU LEU ARG LEU SEQRES 5 A 133 ALA SER PHE TYR ASP TRP PRO LEU THR ALA GLU VAL PRO SEQRES 6 A 133 PRO GLU LEU LEU ALA ALA ALA GLY PHE PHE HIS THR GLY SEQRES 7 A 133 HIS GLN ASP LYS VAL ARG CYS PHE PHE CYS TYR GLY GLY SEQRES 8 A 133 LEU GLN SER TRP LYS ARG GLY ASP ASP PRO TRP THR GLU SEQRES 9 A 133 HIS ALA LYS TRP PHE PRO GLY CYS GLN PHE LEU LEU ARG SEQRES 10 A 133 SER LYS GLY GLN GLU TYR ILE ASN ASN ILE HIS LEU THR SEQRES 11 A 133 HIS SER LEU SEQRES 1 B 133 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 133 GLU VAL PRO ARG GLY SER HIS MET LEU GLU THR GLU GLU SEQRES 3 B 133 GLU GLU GLU GLU GLY ALA GLY ALA THR LEU SER ARG GLY SEQRES 4 B 133 PRO ALA PHE PRO GLY MET GLY SER GLU GLU LEU ARG LEU SEQRES 5 B 133 ALA SER PHE TYR ASP TRP PRO LEU THR ALA GLU VAL PRO SEQRES 6 B 133 PRO GLU LEU LEU ALA ALA ALA GLY PHE PHE HIS THR GLY SEQRES 7 B 133 HIS GLN ASP LYS VAL ARG CYS PHE PHE CYS TYR GLY GLY SEQRES 8 B 133 LEU GLN SER TRP LYS ARG GLY ASP ASP PRO TRP THR GLU SEQRES 9 B 133 HIS ALA LYS TRP PHE PRO GLY CYS GLN PHE LEU LEU ARG SEQRES 10 B 133 SER LYS GLY GLN GLU TYR ILE ASN ASN ILE HIS LEU THR SEQRES 11 B 133 HIS SER LEU HET ZN A1001 1 HET 419 A 1 38 HET ZN B1001 1 HET LI B1002 1 HET 419 B 1 38 HET BTB B 173 14 HET EDO B 174 4 HET EDO B 175 4 HETNAM ZN ZINC ION HETNAM 419 N-[(3AR,6S,6AS)-1-(N-METHYL-L-ALANYL-3-METHYL-L-VALYL) HETNAM 2 419 OCTAHYDROCYCLOPENTA[B]PYRROL-6-YL]-2,2- HETNAM 3 419 DIPHENYLACETAMIDE HETNAM LI LITHIUM ION HETNAM BTB 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL- HETNAM 2 BTB PROPANE-1,3-DIOL HETNAM EDO 1,2-ETHANEDIOL HETSYN BTB BIS-TRIS BUFFER HETSYN EDO ETHYLENE GLYCOL FORMUL 3 ZN 2(ZN 2+) FORMUL 4 419 2(C31 H42 N4 O3) FORMUL 6 LI LI 1+ FORMUL 8 BTB C8 H19 N O5 FORMUL 9 EDO 2(C2 H6 O2) FORMUL 11 HOH *209(H2 O) HELIX 1 1 PHE A 81 GLY A 85 5 5 HELIX 2 2 SER A 86 SER A 93 1 8 HELIX 3 3 PRO A 104 ALA A 111 1 8 HELIX 4 4 ASP A 139 PHE A 148 1 10 HELIX 5 5 CYS A 151 GLY A 159 1 9 HELIX 6 6 GLY A 159 HIS A 167 1 9 HELIX 7 7 PHE B 81 GLY B 85 5 5 HELIX 8 8 SER B 86 SER B 93 1 8 HELIX 9 9 PHE B 94 TRP B 97 5 4 HELIX 10 10 PRO B 104 ALA B 111 1 8 HELIX 11 11 ASP B 139 PHE B 148 1 10 HELIX 12 12 CYS B 151 GLY B 159 1 9 HELIX 13 13 GLY B 159 HIS B 170 1 12 SHEET 1 A 3 PHE A 113 HIS A 115 0 SHEET 2 A 3 VAL A 122 CYS A 124 -1 O ARG A 123 N PHE A 114 SHEET 3 A 3 GLY A 130 LEU A 131 -1 O LEU A 131 N VAL A 122 SHEET 1 B 3 PHE B 113 HIS B 115 0 SHEET 2 B 3 VAL B 122 CYS B 124 -1 O ARG B 123 N PHE B 114 SHEET 3 B 3 GLY B 130 LEU B 131 -1 O LEU B 131 N VAL B 122 LINK SG CYS A 124 ZN ZN A1001 1555 1555 2.34 LINK SG CYS A 127 ZN ZN A1001 1555 1555 2.34 LINK NE2 HIS A 144 ZN ZN A1001 1555 1555 2.11 LINK SG CYS A 151 ZN ZN A1001 1555 1555 2.32 LINK O SER B 93 LI LI B1002 1555 1555 1.86 LINK OD1 ASP B 96 LI LI B1002 1555 1555 1.83 LINK ND1 HIS B 115 LI LI B1002 1555 1555 1.96 LINK SG CYS B 124 ZN ZN B1001 1555 1555 2.33 LINK SG CYS B 127 ZN ZN B1001 1555 1555 2.33 LINK NE2 HIS B 144 ZN ZN B1001 1555 1555 2.12 LINK SG CYS B 151 ZN ZN B1001 1555 1555 2.32 LINK O2 EDO B 174 LI LI B1002 1555 1555 1.84 SITE 1 AC1 4 CYS A 124 CYS A 127 HIS A 144 CYS A 151 SITE 1 AC2 13 LYS A 121 VAL A 122 ARG A 123 GLY A 130 SITE 2 AC2 13 LEU A 131 GLN A 132 SER A 133 TRP A 134 SITE 3 AC2 13 ASP A 138 GLU A 143 TRP A 147 HOH A 287 SITE 4 AC2 13 ARG B 136 SITE 1 AC3 4 CYS B 124 CYS B 127 HIS B 144 CYS B 151 SITE 1 AC4 4 SER B 93 ASP B 96 HIS B 115 EDO B 174 SITE 1 AC5 17 PRO A 104 GLU A 106 LEU A 107 ASP A 139 SITE 2 AC5 17 LYS B 121 VAL B 122 ARG B 123 GLY B 130 SITE 3 AC5 17 LEU B 131 GLN B 132 SER B 133 TRP B 134 SITE 4 AC5 17 ASP B 138 GLU B 143 TRP B 147 HOH B 288 SITE 5 AC5 17 HOH B 305 SITE 1 AC6 8 PRO B 82 LYS B 146 TRP B 147 HIS B 167 SITE 2 AC6 8 HIS B 170 HOH B 192 HOH B 276 HOH B 300 SITE 1 AC7 9 SER A 93 HOH B 31 SER B 93 ASP B 96 SITE 2 AC7 9 HIS B 115 GLY B 117 HOH B 236 HOH B 265 SITE 3 AC7 9 LI B1002 SITE 1 AC8 6 CYS B 127 PHE B 148 PRO B 149 GLY B 150 SITE 2 AC8 6 HOH B 204 HOH B 240 CRYST1 88.048 88.048 73.321 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011357 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011357 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013639 0.00000